This is interesting because the SUM-229 line is a KRAS-transformed cell line that falls into the basal/claudin-low subset of triple-negative breast cancers and has been predicted by others to be enriched for expression of genes in the TGF-beta pathway37–40. Here, KRAS is linked to triple-negative breast carcinoma.